Financials

  • Market Capitalization 39.32 B
  • Employee 883
  • Founded 2014
  • CEO N/A
  • Website www.revmed.com
  • Headquarter Delaware, United States
  • FIGI BBG00829F4P8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-13.39
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
240
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
656.11 USD-1.05%-2.98%+6.97%+14.59%68.79 B USD
295
ARGX
argenx SE - American Depositary Shares
859.14 USD-1.95%-6.61%-3.76%+51.52%53.17 B USD
387
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
281.31 USD-2.34%-12.53%-0.57%-11.23%37.56 B USD
492
MRNA
Moderna, Inc. - Common Stock
67.45 USD+0.66%-15.44%+31.28%+103.22%26.76 B USD

Notizie